tiprankstipranks
Adaptimmune Therapeutics (ADAPY)
OTHER OTC:ADAPY
US Market
Want to see ADAPY full AI Analyst Report?

Adaptimmune Therapeutics (ADAPY) Technical Analysis

1,252 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
4Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Adaptimmune Therapeutics’s (ADAPY) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Adaptimmune Therapeutics is a Buy.
Adaptimmune Therapeutics’s (ADAPY) 20-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) 50-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.

Adaptimmune Therapeutics (ADAPY) Pivot Points

Apr 30, 2026, 06:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
<0.01
<0.01
<0.01
<0.01
0.01
0.01
0.02
Fibonacci
<0.01
<0.01
<0.01
<0.01
0.01
0.01
0.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Adaptimmune Therapeutics (ADAPY) Moving Averages

Apr 30, 2026, 06:35 AM
Period
Simple
Exponential
MA5
0.02Buy
0.02Buy
MA10
0.02Buy
0.02Buy
MA20
0.02Buy
0.02Buy
MA50
0.02Sell
0.02Sell
MA100
0.03Sell
0.04Sell
MA200
0.08Sell
0.10Sell
Adaptimmune Therapeutics’s (ADAPY) 10-Day exponential moving average is 0.02, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) 100-Day exponential moving average is 0.04, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Sell.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 50-day simple moving average is 0.02, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 100-day simple moving average is 0.03, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 200-day simple moving average is 0.08, creating a Sell signal.

Adaptimmune Therapeutics (ADAPY) Technical Indicators

Apr 30, 2026, 06:35 AM
Name
Value
Implied Action
RSI (14)
50.45
Neutral
STOCH (9,6)
73.79
Neutral
STOCHRSI (14)
68.12
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
60.83
Sell
Williams %R
-17.39
Sell
CCI (14)
-29.33
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
85.97
Buy
ROC
0.00
Sell
Adaptimmune Therapeutics’s (ADAPY) Relative Strength Index (RSI) is 50.45, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAPY) Trend Strength Indicator (ADX) is 60.83, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAPY) Commodity Channel Index (CCI) is -29.33, creating a Neutral signal.

FAQ

Is ADAPY a Buy, Hold, or Sell?
Based on ADAPY’s technical indicators, ADAPY is a Hold.
    What is ADAPY’s RSI (14)?
    ADAPY’s RSI (14) is 50.45, which suggests ADAPY is a Neutral.
      What is ADAPY’s MACD?
      ADAPY’s MACD is >-0.01, which suggests ADAPY is a Buy.
        What is ADAPY’s 5-day moving average?
        ADAPY’s 5-day moving average is 0.02, which suggests ADAPY is a Buy.
          What is ADAPY’s 20-day moving average?
          ADAPY 20-day moving average is 0.02, which suggests ADAPY is a Buy.
            What is ADAPY’s 50-day moving average?
            ADAPY’s 50-day moving average is 0.02, which suggests ADAPY is a Sell.
              What is ADAPY’s 200-day moving average?
              ADAPY’s 200-day moving average is 0.08, which suggests ADAPY is a Sell.
                What is ADAPY’s Williams % R (14)?
                ADAPY’s Williams % R (14) is -17.39, which suggests ADAPY is a Sell.
                  What is ADAPY’s CCI (14)?
                  ADAPY’s CCI (14) is -29.33, which suggests ADAPY is a Neutral.